News

Oncolytic Virus Therapy Market Trends, Share, Forecast, Overview and Analysis by 2028

September 6, 2021

The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. The report provides detailed insights into Oncolytic Virus Therapy market trends, industry trends, consumer trends, market size, market share, market revenue growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in Oncolytic Virus Therapy market size over the forecast period, 2020–2028. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. The Oncolytic Virus Therapy report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/541

Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body. Varying market trends can be attributed to inclining revenue growth of the global Oncolytic Virus Therapy market going ahead. Oncolytic Virus Therapy Market trends include rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition. Other positive Oncolytic Virus Therapy market trends include rising demand and deployment in respective sectors/industries in major and developing countries. In addition, implementation of favorable government policies, advancements in technology, and steady economic growth across various regions and countries are factors expected to continue to result in further Oncolytic Virus Therapy market trend evolution and changes going ahead.

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/oncolytic-virus-therapy-market

In terms of Oncolytic Virus Therapy market share and revenue contribution to the global Oncolytic Virus Therapy market, North America is expected to maintain its dominance over other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting rapid increase in Oncolytic Virus Therapy market share.

The market intelligence report on the Oncolytic Virus Therapy Industry also includes an extensive investigation of the competitive landscape. It assesses the business and marketing strategies expected to be present in the market through the forecast years. It also includes an investigation of the recent advancements and other factors driving the growth of the overall market to help comprehend the progress of the companies in the coming years.

Some Key Highlights in the Report

In October 2020, Oncolytics Biotech made announced the signing of a partnership agreement with AIO and Roche to commence a Phase ½ trial(GOBLET) for gastrointestinal cancer. The trial would examine the use of pelareorep with anti-PD-L1 checkpoint inhibitor by Roche in cancer patients.
Monoclonal antibodies are considered beneficial in stimulating immune responses to destroy cancer cells. In addition, certain monoclonal antibodies are capable of blocking the connection between the cellular growth promoting proteins and cancer cells, thereby killing the cancer cells.
Oncolytic virus therapy in the treatment of lung cancer is used to deliver specific immunomodulatory or therapeutic genes to destroy cancer cells. Oncolytic virus therapy holds significant potential to improve tumor cell oncolysis and circumvent resistance mechanisms of tumor cells. It was estimated that in 2020, over 0.2 million adults in the US were diagnosed with lung cancer, which accounted for around 13.0% of the total individuals diagnosed with cancer in the same year.
The North America oncolytic virus therapy accounted for largest revenue share in the global oncolytic virus therapy market in 2020, which can be attributed to rising incidence of cancer, particularly among the elderly population. Furthermore, presence of major oncolytic virus therapy firms and rising investments in cancer immunotherapy is a major factor driving growth of the market in the region.
Key players in the market include Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH & Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.

Read Trending news@ Investor Welcome

Region wise performance of the Oncolytic Virus Therapy industry

North America Oncolytic Virus Therapy market trend scenario has significant impact on other regional market trends. North America Oncolytic Virus Therapy market accounted for largest revenue share in 2020 and is expected to continue to maintain its dominance over other regional markets over the forecast period. Presence of major players in countries in the region is a key factor driving steady change in overall Oncolytic Virus Therapy market trends.

Asia Pacific Oncolytic Virus Therapy market is expected to register comparatively faster revenue growth than other regional markets over the forecast period. This can be attributed to varying Oncolytic Virus Therapy market trend scenarios in countries such as China, India, South Korea, and others. These scenarios with regard to domestic market trends and international market trends and varying impacts play a major role in growth of the Asia Pacific market.

Asia Pacific market share contribution to the global Oncolytic Virus Therapy market is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028. Increasing population, favorable government policies and initiatives, rising disposable income among consumers in countries in the region, influence of Oncolytic Virus Therapy market trends in other countries and regions, and steady economic growth are some key factors driving market revenue growth of the Asia Pacific Oncolytic Virus Therapy market.

Europe Oncolytic Virus Therapy market size and revenue growth is primarily supported by Oncolytic Virus Therapy market trends such as continuous developments in major countries in the region, robust focus on research and development initiatives by major firms, and changing market trends in countries in other major regions.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Fill up the Form to get exciting Discount on this Oncolytic Virus Therapy Report@ https://www.emergenresearch.com/request-discount/541

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Oncolytic Virus Therapy industry for the forecast period 2020-2027?
What are the major driving forces expected to impact the development of the Oncolytic Virus Therapy market across different regions?
Who are the major driving forces expected to decide the fate of the Oncolytic Virus Therapy industry worldwide?
Who are the prominent market players making a mark in the Oncolytic Virus Therapy market with their winning strategies?
Which Oncolytic Virus Therapy industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Oncolytic Virus Therapy market?

Why Choose Emergen Research?